lm 985 has been researched along with Adenocarcinoma, Basal Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briet, P; Dykes, D; Narayanan, VL; Paull, KD; Plowman, J; Szarvasi, E; Yoder, OC | 1 |
| Bibby, MC; Double, JA; Loadman, PM | 1 |
| Bibby, MC; Double, JA; Loadman, PM; Phillips, RM | 1 |
3 other study(ies) available for lm 985 and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation, Preclinical; Flavonoids; Leukemia L1210; Leukemia P388; Mice | 1986 |
Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colon.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Flavonoids; Humans; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation | 1986 |
Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid).
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Drug Administration Schedule; Flavonoids; Mice; Mice, Inbred Strains; Neoplastic Stem Cells; Peritoneum | 1987 |